Skip to main content
Caplight Logo









Algen Biotechnologies

Algen Biotechnologies

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.algenbio.com/

Last Round

Seed

Aug 31, 2021

Total Funding Raised

$5.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Algen Biotechnologies is a biotechnology company that has developed a platform for therapeutics and drug discovery using CRISPR and AI to find treatments for cancer, inflammation and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformCRISPR platformtherapeutic target identificationtechbiogene modulationfull-stack drug discoverycausal biologyfunctional genomicsplatform therapeuticsgenerative biologyoncology drug discoveryinternal drug pipelinedisease modelingpharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Algen Biotechnologies Comparables

Compare Algen Biotechnologies with similar companies based on industry and business-model similarity.

Algen Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insitro
83%
Transcripta Bio
81%
Myllia Biotechnology
81%

Algen Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 31, 2021

Algen Biotechnologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 16, 2026

    Grew 25% QoQ, from 16 to 20 employees.

  • Jul 26, 2026

    Monthly visitors increased 36% MoM, reaching 2.1K.

Algen Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Algen Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Algen Biotechnologies's valuation, stock price, and market status.

Is Algen Biotechnologies a public or private company?

Algen Biotechnologies is a private company.

What is the current stock price of Algen Biotechnologies?

Algen Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Algen Biotechnologies worth (valuation)?

Valuation information for Algen Biotechnologies is not publicly available.

Can I buy Algen Biotechnologies stock?

Algen Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Algen Biotechnologies's last funding round?

Funding round information for Algen Biotechnologies is not publicly available.

Who are the main investors in Algen Biotechnologies?

Investor information for Algen Biotechnologies is not publicly disclosed.

Will Algen Biotechnologies IPO soon?

No public IPO plans have been announced for Algen Biotechnologies.

How can I track Algen Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Algen Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range14
Year Founded2018
Last FundingAug 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?